Amylin Pharmaceuticals Announces Public Offering of Common Stock; No Amount Given

Amylin Pharmaceuticals, Inc.

today announced that it is offering to sell shares of its common stock in an underwritten public offering. Credit Suisse Securities LLC is acting as sole book-running manager and underwriter in this offering.